123 results
Page 4 of 7
6-K
za5e6213te mi5
23 Nov 20
Current report (foreign)
6:05am
6-K
EX-99.3
2bci5bjq
23 Nov 20
Mesoblast Enters Global Collaboration for Development, Manufacture and Commercialization of Remestemcel-l
6:04am
6-K
EX-99.1
k8hwo84yw0vaho5 1j
29 Oct 20
Current report (foreign)
6:02am
6-K
EX-99.2
b5i0ligibfgmy
29 Oct 20
Current report (foreign)
6:02am
6-K
EX-99.1
jzayyfh7r67hrndo3
28 Aug 20
Mesoblast Well Prepared Ahead of First Potential US Product Launch
8:48pm
6-K
EX-99.2
geqkv376uubyfg4
28 Aug 20
Mesoblast Well Prepared Ahead of First Potential US Product Launch
8:48pm
6-K
q3okpfxe5c1hl8fq38
29 May 20
Current report (foreign)
12:00am
6-K
EX-99.2
tc76yggqa8cmk3ax
29 May 20
Current report (foreign)
12:00am
6-K
o3x7t1u 72yf
28 Feb 20
Provided to the Asx Under Listing Rule 4.2A
12:00am
6-K
EX-99.2
rmsnedl 8airp
22 Jan 20
Mesoblast Presents Commercial Plans at 2020 Biotech Showcase In San Francisco
4:49pm
6-K
EX-99.2
tpg8n7vqzgz3vabi9
29 Nov 19
Current report (foreign)
6:47am
6-K
EX-99.1
vcgdilt oc3oyyx
29 Nov 19
Current report (foreign)
6:47am
6-K
tyrkba9 0qdqjln2j80
27 Nov 19
Current report (foreign)
6:04am
6-K
EX-99.2
3uyk0
27 Nov 19
Continued Increase in Revenues and Strong Balance Sheet
6:04am
6-K
EX-99.2
0p5s3
1 Nov 19
Appointment of Joint Company Secretary
6:02am
6-K
EX-99.1
recptr7yqr0cf6k fcl
21 Oct 19
Mesoblast and Lonza Enter into Agreement for Commercial Manufacture of Mesoblast’s Potential First United States Allogeneic Cell Therapy
8:19pm
6-K
EX-99.1
ak0y0wp
3 Oct 19
Current report (foreign)
6:03am
6-K
EX-99.2
k0mtbyaq9xe
11 Sep 19
Current report (foreign)
6:35am